Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:00 pm Purchase |
2025-02-11 | 13D | Sera Prognostics, Inc. SERA |
Chione Ltd. | 2,605,351 7.600% |
625,001 (+31.56%) |
Filing History |
| 2024-07-10 8:34 pm Unchanged |
2024-06-30 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Chione Ltd. | 3,848,632 12.500% |
0 (Unchanged) |
Filing History |
| 2024-07-10 8:29 pm Sale |
2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Chione Ltd. | 3,848,632 17.300% |
-7,965 (-0.21%) |
Filing History |
| 2023-02-14 3:41 pm Sale |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd. | 293,333 3.900% |
-40,000 (-12.00%) |
Filing History |
| 2022-11-28 3:59 pm Purchase |
2022-11-17 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Chione Ltd. | 3,856,597 18.500% |
3,856,597 (New Position) |
Filing History |
| 2022-02-11 2:54 pm Sale |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd. | 333,333 6.600% |
-33,333 (-9.09%) |
Filing History |
| 2021-07-26 5:19 pm Purchase |
2021-07-15 | 13D | Sera Prognostics, Inc. SERA |
Chione Ltd. | 1,980,350 6.800% |
1,980,350 (New Position) |
Filing History |
| 2021-02-16 4:03 pm Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd. | 366,667 7.500% |
-13,033 (-3.43%) |
Filing History |